| Symbol | Company | Weighting |
|---|---|---|
| GH | GUARDANT HEALTH INC | 2.43% |
| BEAM | BEAM THERAPEUTICS INC | 2.26% |
| DNLI | DENALI THERAPEUTICS INC. | 2.23% |
| UTHR | UNITED THERAPEUTICS CORPS | 2.19% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 2.06% |
| CYTK | CYTOKINETICS INC | 2.04% |
| NTRA | NATERA INC | 2.03% |
| APLS | APELLIS PHARMACEUTICALS INC | 2.00% |
| HQY | HEALTHEQUITY INC | 1.99% |
| CERE | CEREVEL THERAPEUTICS HLD | 1.96% |
| ARGX | ARGENX SE ADR | 1.95% |
| RMD | RESMED INC | 1.94% |
| ICLR | ICON PLC | 1.94% |
| SRPT | SAREPTA THERAPEUTICS INC | 1.91% |
| NVO | NOVO NORDISK A/S | 1.91% |
| RGEN | REPLIGEN CORP | 1.90% |
| ZTS | ZOETIS INC | 1.90% |
| UNH | UNITEDHEALTH GROUP INC | 1.89% |
| IQV | IQVIA HOLDINGS INC | 1.88% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 1.86% |
| ADUS | ADDUS HOMECARE CORPORATION | 1.84% |
| AZN | ASTRAZENECA PLC-ADR | 1.84% |
| SYNH | SYNEOS HEALTH INC | 1.83% |
| BMY | BRISTOL MYERS SQUIBB CO | 1.82% |
| AVTR | AVANTOR, INC. | 1.82% |
| BDX | BECTON DICKINSON & CO | 1.77% |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 1.76% |
| MASI | MASIMO CORP | 1.75% |
| ABBV | ABBVIE INC | 1.75% |
| HUM | HUMANA INC | 1.74% |
| LIVN | LIVANOVA PLC | 1.74% |
| ABT | ABBOTT LABORATORIES | 1.73% |
| CI | CIGNA CORP NEW | 1.72% |
| MCK | MCKESSON CORP | 1.72% |
| ACHC | ACADIA HEALTHCARE CO INC | 1.71% |
| ABC | AMERISOURCEBERGEN CORP | 1.70% |
| LNTH | LANTHEUS HOLDINGS INC | 1.69% |
| DXCM | DEXCOM INC | 1.69% |
| ITCI | INTRA-CELLULAR THERAPIES USD | 1.69% |
| OMI | OWENS & MINOR INC NEW | 1.68% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.66% |
| BSX | BOSTON SCIENTIFIC | 1.66% |
| NUVA | NUVASIVE | 1.65% |
| HZNP | HORIZON THERAPEUTICS PLC | 1.64% |
| REGN | REGENERON PHARMACEUTICALS | 1.64% |
| MOH | MOLINA HEALTHCARE INC | 1.58% |
| SYK | STRYKER CORP | 1.56% |
| MDRX | ALLSCRIPTS HEALTHCARE SOLUTIONS INC | 1.55% |
| HCA | HCA HOLDINGS INC | 1.50% |
| ILMN | ILLUMINA INC | 1.37% |
| QURE | UNIQURE NV | 1.23% |
| RCKT | ROCKET PHARMACEUTICALS INC USD | 1.17% |
| XNCR | XENCOR INC. | 0.99% |
| XENE | XENON PHARMACEUTICALS | 0.91% |
| RNA | AVIDITY BIOSCIENCES INC | 0.87% |
| TVTX | TRAVERE THERAPEUTICS INC | 0.85% |
| RXDX | PROMETHEUS BIOSCIENCES | 0.82% |
| AMPH | AMPHASTAR PHARMACEUTICALS INC | 0.81% |
| AXSM | AXSOME THERAPEUTICS INC. | 0.66% |
| EYPT | EYEPOINT PHARMACEUTICALS | 0.63% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Partners Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Fund Management (Europe) Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Partners India Management. Securities offered through Guggenheim Funds Distributors, LLC.
© 2022 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.